Product Details

Teicoplanin for Injection BP is manufactured to strict BP-standard specifications for use in the treatment of serious bacterial infections. It is prescribed for patients requiring hospital-based antibiotic therapy.

The injection combines:

• Teicoplanin — a glycopeptide antibiotic that inhibits bacterial cell wall synthesis, causing cell lysis and death in susceptible Gram-positive organisms

Teicoplanin for Injection BP is indicated in the treatment of serious Gram-positive infections, including those caused by MRSA and other resistant staphylococci. As a result, it is administered under medical supervision, typically in hospital wards and outpatient antibiotic therapy settings.

Key Features:

• Manufactured to BP-standard compliance for consistent quality
• Sterile powder ensures stability before reconstitution
• Accurate potency per vial supports precise dosing in antibiotic therapy
• Suitable for both intravenous and intramuscular administration
• Single Dose Vial format minimizes contamination risk
• Suitable for hospital pharmacies and institutional supply